Cargando…

Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years experience

BACKGROUND: Phenylketonuria (PKU) is an autosomal recessive disorder caused by the deficiency of phenylalanine hydroxylase that catalyzes the conversion of phenylalanine to tyrosine, using tetrahydrobiopterin (BH4) as coenzyme. Besides dietary phenylalanine restriction, new therapeutic options are e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scala, Iris, Concolino, Daniela, Casa, Roberto Della, Nastasi, Anna, Ungaro, Carla, Paladino, Serena, Capaldo, Brunella, Ruoppolo, Margherita, Daniele, Aurora, Bonapace, Giuseppe, Strisciuglio, Pietro, Parenti, Giancarlo, Andria, Generoso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351928/ https://www.ncbi.nlm.nih.gov/pubmed/25757997 http://dx.doi.org/10.1186/s13023-015-0227-8

Ejemplares similares

Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
por: Scala, Iris, et al.
Publicado: (2021)

New Strategies for the Treatment of Phenylketonuria (PKU)
por: Strisciuglio, Pietro, et al.
Publicado: (2014)

Large Neutral Amino Acids (LNAAs) Supplementation Improves Neuropsychological Performances in Adult Patients with Phenylketonuria
por: Scala, Iris, et al.
Publicado: (2020)

Molecular genetics of phenylketonuria and tetrahydrobiopterin deficiency in Jordan
por: Carducci, Carla, et al.
Publicado: (2020)

Influencing Factors on the Use of Tetrahydrobiopterin in Patients with Phenylketonuria
por: Gao, Hui
Publicado: (2022)

Co-existence of Phenylketonuria and Fabry disease on a 3 year-old boy: case report
por: Concolino, Daniela, et al.
Publicado: (2010)

Long-term treatment of phenylketonuria with a new medical food containing large neutral amino acids
por: Concolino, D, et al.
Publicado: (2017)

Erratum: Long-term treatment of phenylketonuria with a new medical food containing large neutral amino acids
por: Concolino, D, et al.
Publicado: (2017)

The neonatal tetrahydrobiopterin loading test in phenylketonuria: what is the predictive value?
por: Anjema, Karen, et al.
Publicado: (2016)

The effects of tetrahydrobiopterin (BH(4)) treatment on brain function in individuals with phenylketonuria()
por: Christ, Shawn E., et al.
Publicado: (2013)

Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype
por: Anjema, Karen, et al.
Publicado: (2013)

Correlation between genotype and the tetrahydrobiopterin-responsive phenotype in Chinese patients with phenylketonuria
por: Tao, Jing, et al.
Publicado: (2015)

Tetrahydrobiopterin responsiveness in a series of 53 cases of phenylketonuria and hyperphenylalaninemia in Iran
por: Setoodeh, Aria, et al.
Publicado: (2015)

Involvement of endocrine system in a patient affected by Glycogen storage disease 1b: speculation on the role of autoimmunity
por: Melis, Daniela, et al.
Publicado: (2014)

Massive parallel sequencing as a new diagnostic approach for phenylketonuria and tetrahydrobiopterin-deficiency in Thailand
por: Chaiyasap, Pongsathorn, et al.
Publicado: (2017)

Genotype-phenotype associations in French patients with phenylketonuria and importance of genotype for full assessment of tetrahydrobiopterin responsiveness
por: Jeannesson-Thivisol, Elise, et al.
Publicado: (2015)

Improvement of dysphagia in a child affected by Pompe disease treated with enzyme replacement therapy
por: Fecarotta, Simona, et al.
Publicado: (2013)

The first case of mitochondrial acetoacetyl-CoA thiolase deficiency identified by expanded newborn metabolic screening in Italy: the importance of an integrated diagnostic approach
por: Catanzano, Francesca, et al.
Publicado: (2010)

One-year follow-up of B vitamin and Iron status in patients with phenylketonuria provided tetrahydrobiopterin (BH4)
por: Brantley, Kristen D, et al.
Publicado: (2018)

The challenge of long-term tetrahydrobiopterin (BH(4)) therapy in phenylketonuria: Effects on metabolic control, nutritional habits and nutrient supply
por: Thiele, Alena G., et al.
Publicado: (2015)

S1.2 The pediatrician and the early onset Pompe disease
por: Fecarotta, Simona, et al.
Publicado: (2011)

Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation
por: Melis, Daniela, et al.
Publicado: (2015)

Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia
por: Rossi, Alessandro, et al.
Publicado: (2023)

S2.2 Enzyme replacement therapy in the infantile-onset Pompe disease
por: Parenti, Giancarlo, et al.
Publicado: (2011)

Immune responses to alglucosidase in infantile Pompe disease: recommendations from an Italian pediatric expert panel
por: Gragnaniello, Vincenza, et al.
Publicado: (2022)

Evaluation of Tetrahydrobiopterin Therapy with Large Neutral Amino Acid Supplementation in Phenylketonuria: Effects on Potential Peripheral Biomarkers, Melatonin and Dopamine, for Brain Monoamine Neurotransmitters
por: Yano, Shoji, et al.
Publicado: (2016)

Respiratory manifestations in patients with inherited metabolic diseases
por: Santamaria, Francesca, et al.
Publicado: (2013)

Galactosemia: Biochemistry, Molecular Genetics, Newborn Screening, and Treatment
por: Succoio, Mariangela, et al.
Publicado: (2022)

Imbalanced cortisol concentrations in glycogen storage disease type I: evidence for a possible link between endocrine regulation and metabolic derangement
por: Rossi, Alessandro, et al.
Publicado: (2020)

A case of galactosemia misdiagnosed as cow’s milk intolerance
por: Casa, Roberto Della, et al.
Publicado: (2012)

Central Tetrahydrobiopterin Concentration in Neurodevelopmental Disorders
por: Frye, Richard E.
Publicado: (2010)

Modulation of Radiation Response by the Tetrahydrobiopterin Pathway
por: Pathak, Rupak, et al.
Publicado: (2015)

Phenylketonuria
por: Hudson, Frederick
Publicado: (1969)

An exceptional Albanian family with seven children presenting with dysmorphic features and mental retardation: maternal phenylketonuria
por: Knerr, Ina, et al.
Publicado: (2005)

Long-term monitoring for short/branched-chain acyl-CoA dehydrogenase deficiency: A single-center 4-year experience and open issues
por: Rossi, Alessandro, et al.
Publicado: (2022)

Mast cell tetrahydrobiopterin contributes to itch in mice
por: Zschiebsch, Katja, et al.
Publicado: (2018)

Kynurenine and Tetrahydrobiopterin Pathways Crosstalk in Pain Hypersensitivity
por: Staats Pires, Ananda, et al.
Publicado: (2020)

Tetrahydrobiopterin deficiencies: Lesson from clinical experience
por: Bozaci, Ayse Ergul, et al.
Publicado: (2021)

A key role for tetrahydrobiopterin‐dependent endothelial NOS regulation in resistance arteries: studies in endothelial cell tetrahydrobiopterin‐deficient mice
por: Chuaiphichai, Surawee, et al.
Publicado: (2017)

Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome
por: Granese, Barbara, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nf3351hn6ej78e9pns95rehpop